WGS — GeneDx Holdings Income Statement
0.000.00%
- $832.38m
- $771.76m
- $202.57m
- 48
- 20
- 96
- 54
Annual income statement for GeneDx Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 196 | 179 | 212 | 235 | 203 |
Cost of Revenue | |||||
Gross Profit | 76.6 | -5.33 | -16.6 | -26.8 | 90 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 227 | 421 | 659 | 902 | 386 |
Operating Profit | -30.4 | -242 | -446 | -668 | -183 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -29.7 | -241 | -245 | -598 | -177 |
Provision for Income Taxes | |||||
Net Income After Taxes | -29.7 | -241 | -245 | -549 | -176 |
Net Income Before Extraordinary Items | |||||
Net Income | -29.7 | -241 | -245 | -549 | -176 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -32.7 | -241 | -245 | -549 | -176 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -4.57 | -33.3 | -33 | -51.1 | -6.75 |